Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ALMOTRIPTAN MALATE USP [ROUTE CODE - AM], with a corresponding US DMF Number 25327.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 09, 2021, and payment made on February 02, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II